Skip to article
Astra

Allergy and Immunology

Anaphylaxis

Recognize anaphylaxis clinically, administer intramuscular epinephrine without delay, support airway and circulation, and escalate promptly when symptoms persist. Observation, discharge preparedness, and allergy evaluation reduce risk from recurrence, biphasic reactions, and avoidable re-exposure.

Clinical question: How should physicians diagnose, treat, monitor, and prevent recurrence after suspected anaphylaxis?

Diagnosis

Recognize anaphylaxis clinically

The immediate decision is whether airway, breathing, or circulation involvement warrants epinephrine.

Anaphylaxis is highly likely with acute skin or mucosal involvement plus respiratory compromise or hypotension/end-organ symptoms; with rapid involvement of at least two systems after a likely allergen; or with hypotension after a known allergen. For adults, hypotension is systolic blood pressure below 90 mm Hg or a decrease greater than 30% from baseline. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)

Absence of hives or angioedema does not exclude anaphylaxis. This is particularly important in perioperative reactions, where cardiovascular and respiratory compromise may predominate, and in patients with abrupt bronchospasm, laryngeal symptoms, or hypotension after a probable exposure. BMJAnaphylaxis - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedRecent update on the management of anaphylaxis

Treat the clinical syndrome rather than waiting for confirmatory testing. Serum tryptase may support retrospective confirmation, but it lacks sensitivity and should not alter immediate resuscitation. Paired acute and baseline samples are more informative than a single value; one review describes acute sampling between 30 minutes and 2 hours after symptom onset and baseline sampling at least 24 hours after complete resolution. PubMedRecent update on the management of anaphylaxis

Clinical features that should prompt treatment for anaphylaxis rather than isolated allergic symptoms. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
PresentationAction
Acute skin or mucosal symptoms plus dyspnea, wheeze, stridor, hypoxemia, or hypotensionTreat as anaphylaxis with IM epinephrine. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
Rapid multisystem reaction after likely allergen, including persistent vomiting or abdominal cramping with skin, respiratory, or circulatory findingsTreat as anaphylaxis with IM epinephrine. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
Acute bronchospasm, laryngeal involvement, or hypotension after known or probable allergen, with or without rashTreat as anaphylaxis with IM epinephrine. BMJAnaphylaxis - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)

Emergency management

Give intramuscular epinephrine first

IM epinephrine is first-line therapy for airway, respiratory, or circulatory anaphylaxis.

Use epinephrine 1 mg/mL IM in the anterolateral thigh. FDA labeling supports 0.3-0.5 mg for adults and children weighing 30 kg or more, and 0.01 mg/kg for children under 30 kg, with a maximum 0.3 mg per injection; repeat every 5-10 minutes as clinically necessary. The thigh is preferred because of its size and blood flow. dailymed nlm nihDailyMed - ADRENALIN- epinephrine injectiondailymed nlm nihThese highlights do not include all the information needed to use EPINEPHRINE INJECTION safely and effectively. See full prescribing information for EPINEPHRINE INJECTION. EPINEPHRINE injection, for intravenous, intramuscular, subcutaneous useInitial U.S. Approval: 1939

There are no absolute contraindications to epinephrine for life-threatening anaphylaxis. Cardiovascular disease, advanced age, hypertension, and beta-blocker treatment warrant monitoring but should not delay IM treatment. IV bolus epinephrine has substantially greater risk of overdose and cardiovascular complications than IM administration and should not be routine initial therapy outside monitored expert settings. dailymed nlm nihDailyMed - ADRENALIN- epinephrine injectionPubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

Position patients supine when circulatory compromise is present; patients with prominent respiratory distress may require a more upright position. Continuously reassess mental status, airway, respiratory effort, oxygenation, blood pressure, and perfusion. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

Medication roles in acute anaphylaxis. dailymed nlm nihDailyMed - ADRENALIN- epinephrine injectionPubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines
InterventionRole and limitations
Epinephrine IMFirst-line treatment for anaphylaxis; repeat every 5-10 minutes as needed. dailymed nlm nihDailyMed - ADRENALIN- epinephrine injectiondailymed nlm nihThese highlights do not include all the information needed to use EPINEPHRINE INJECTION safely and effectively. See full prescribing information for EPINEPHRINE INJECTION. EPINEPHRINE injection, for intravenous, intramuscular, subcutaneous useInitial U.S. Approval: 1939
Inhaled beta2-agonistAdjunct for persistent bronchospasm or wheeze; does not treat upper-airway edema or shock. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
H1 antihistamineAdjunct for skin and mucosal symptoms after epinephrine; evidence for preventing biphasic reactions is uncertain. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
Systemic corticosteroidNot a substitute for epinephrine; evidence that it prevents biphasic anaphylaxis is uncertain and current literature questions routine use for that purpose. BMJMultiphasic anaphylaxis in the emergency and intensive care setting | BMJ Case ReportsPubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
IV epinephrine infusionFor persistent/refractory anaphylaxis in a monitored setting with clinicians experienced in titration and adverse-effect surveillance. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

Avoid administration errors

For anaphylaxis, inject into the anterolateral thigh—not buttock, digits, hands, feet, or deltoid. Do not repeatedly use the same injection site. Undiluted epinephrine administered intravenously can cause abrupt severe hypertension and cerebral hemorrhage. dailymed nlm nihDailyMed - ADRENALIN- epinephrine injectiondailymed nlm nihThese highlights do not include all the information needed to use EPINEPHRINE INJECTION safely and effectively. See full prescribing information for EPINEPHRINE INJECTION. EPINEPHRINE injection, for intravenous, intramuscular, subcutaneous useInitial U.S. Approval: 1939

Escalation

Escalate persistent or refractory anaphylaxis

Persistent airway, respiratory, or circulatory manifestations require resuscitation-level care.

Definitions vary, but contemporary guidance commonly treats failure to respond adequately after 2 doses of IM epinephrine as a trigger for escalation; a U.S. expert consensus definition uses three or more appropriate epinephrine doses or initiation of IV infusion in addition to symptom-directed management. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

Reassess for continued allergen exposure, inadequate IM delivery, airway obstruction, profound distributive shock, and competing diagnoses. Give additional IM epinephrine while mobilizing critical-care support, providing airway management, and administering rapid IV crystalloid. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

For persistent cardiovascular compromise despite appropriate IM epinephrine and fluids, most reviewed guidelines recommend titrated IV epinephrine infusion with close cardiopulmonary monitoring. The optimum infusion regimen and preferred add-on vasopressor remain uncertain because high-quality comparative data are lacking. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

Refractory-anaphylaxis priorities. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines
ProblemImmediate response
Persistent hypotension or poor perfusion after repeated IM epinephrineCritical-care escalation, rapid crystalloid resuscitation, and titrated IV epinephrine infusion with continuous monitoring. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines
Progressive laryngeal edema, severe stridor, or respiratory failureEarly expert airway management; do not delay until complete obstruction. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines
Ongoing shock despite epinephrine infusion and fluidsEvaluate cardiac function and preload; consider additional vasopressor support under critical-care supervision. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines
Beta-blocker exposure with epinephrine-resistant shockConsider glucagon as an adjunct; evidence is limited. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

Monitoring

Individualize observation and disposition

Biphasic recurrence is uncommon but clinically consequential and risk is not uniform.

Biphasic anaphylaxis is recurrence after apparent resolution without re-exposure. Reported incidence varies substantially because of differing definitions; a recent case-based review cites 0.4% to 23.3%, with many datasets suggesting approximately 4%-6%. BMJMultiphasic anaphylaxis in the emergency and intensive care setting | BMJ Case Reports

Observation duration should reflect initial severity, response to treatment, need for repeated epinephrine, hypotension, persistent symptoms, asthma or other respiratory disease, access to emergency care, and ability to recognize and treat recurrence. Severe, protracted, multiphasic, or refractory reactions require extended monitored care or admission. BMJMultiphasic anaphylaxis in the emergency and intensive care setting | BMJ Case ReportsPubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

The evidence base does not yield a single universally validated observation interval. A guideline reviewed in the supplied literature recommends at least 12 hours of hospital monitoring after symptom relief, particularly for patients with hypotension, whereas other sources describe shorter risk-stratified observation for uncomplicated cases. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

Features associated with increased concern for recurrent or severe disease. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines
FeatureDisposition implication
Hypotension, severe initial reaction, or repeated epinephrine dosesFavor prolonged monitored observation or admission. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines
Persistent or progressive symptomsDo not discharge; continue treatment and reassessment. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines
History of biphasic reaction, beta-blocker use, limited emergency access, or inability to use an autoinjectorUse a lower threshold for extended observation and comprehensive discharge planning. PubMedAnaphylaxis - StatPearls - NCBI Bookshelf - NIH
Uncomplicated response to one IM epinephrine dose with durable recoveryRisk-stratified observation may be reasonable, but a universally optimal duration is not established. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

Secondary prevention

Prevent recurrence after the acute event

A complete discharge plan matters because recurrent exposure is often preventable.

Refer patients after suspected anaphylaxis to an allergy service for trigger assessment, counseling, and prevention planning. Referral is especially important for an uncertain trigger, drug-associated reaction, venom reaction, perioperative event, or recurrent/idiopathic anaphylaxis. nice org ukOverview | Anaphylaxis: assessment and referral after emergency treatment | Guidance | NICEPubMedEvaluating the management of anaphylaxis in US emergency departments: Guidelines vs. practice

Prescribe epinephrine autoinjector therapy and provide practical demonstration. Counseling should include recognition of respiratory and circulatory symptoms, immediate epinephrine use, emergency activation, avoidance of suspected triggers pending evaluation, and awareness that symptoms may recur after an initial response. dailymed nlm nihDailyMed - ADRENALIN- epinephrine injectiondailymed nlm nihThese highlights do not include all the information needed to use EPINEPHRINE INJECTION safely and effectively. See full prescribing information for EPINEPHRINE INJECTION. EPINEPHRINE injection, for intravenous, intramuscular, subcutaneous useInitial U.S. Approval: 1939PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)

Review the medication list and document the suspected culprit with the clinical phenotype and timing, rather than applying an imprecise allergy label. For drug-induced anaphylaxis, report the event through appropriate pharmacovigilance systems and arrange formal allergy evaluation when future use may be clinically important. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)nice org ukOverview | Anaphylaxis: assessment and referral after emergency treatment | Guidance | NICE

High-value discharge elements after anaphylaxis. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)nice org ukOverview | Anaphylaxis: assessment and referral after emergency treatment | Guidance | NICEPubMedEvaluating the management of anaphylaxis in US emergency departments: Guidelines vs. practice
ElementClinical purpose
Epinephrine autoinjector prescription and hands-on teachingEnables immediate treatment of recurrence outside medical settings. dailymed nlm nihDailyMed - ADRENALIN- epinephrine injectiondailymed nlm nihThese highlights do not include all the information needed to use EPINEPHRINE INJECTION safely and effectively. See full prescribing information for EPINEPHRINE INJECTION. EPINEPHRINE injection, for intravenous, intramuscular, subcutaneous useInitial U.S. Approval: 1939PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)
Written emergency action plan and return precautionsReinforces when to use epinephrine and seek emergency care. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedEvaluating the management of anaphylaxis in US emergency departments: Guidelines vs. practice
Trigger documentation and avoidance guidanceReduces re-exposure while evaluation is pending. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)nice org ukOverview | Anaphylaxis: assessment and referral after emergency treatment | Guidance | NICE
Allergy/immunology referralSupports identification of culprit, risk stratification, and preventive treatment. nice org ukOverview | Anaphylaxis: assessment and referral after emergency treatment | Guidance | NICEPubMedEvaluating the management of anaphylaxis in US emergency departments: Guidelines vs. practice
Medication adverse-event reporting when applicableSupports pharmacovigilance for suspected drug-induced anaphylaxis. PubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)

Common questions

Should epinephrine be given when anaphylaxis is suspected but diagnostic criteria are not fully met?

When acute exposure-associated symptoms suggest evolving airway, respiratory, or circulatory involvement, administer IM epinephrine rather than waiting for diagnostic certainty. Clinical criteria are aids to recognition, not prerequisites for treatment. BMJAnaphylaxis - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)

When should serum tryptase be measured?

Tryptase is not needed to initiate treatment. When diagnostic confirmation is useful, obtain an acute sample as soon as feasible after stabilization and a baseline sample at least 24 hours after complete clinical resolution; paired values are more informative than a single measurement. BMJMultiphasic anaphylaxis in the emergency and intensive care setting | BMJ Case ReportsPubMedRecent update on the management of anaphylaxis

Do antihistamines or corticosteroids prevent biphasic anaphylaxis?

Evidence is uncertain. H1 antihistamines may relieve skin and mucosal symptoms after epinephrine, but they do not replace epinephrine. Systemic corticosteroids have not shown clear benefit for preventing biphasic reactions in available reviews. BMJMultiphasic anaphylaxis in the emergency and intensive care setting | BMJ Case ReportsPubMedA Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)PubMedRecent update on the management of anaphylaxis

What defines refractory anaphylaxis?

Definitions differ. Failure to respond adequately after two IM epinephrine doses is commonly used to trigger escalation; U.S. expert consensus has defined refractory anaphylaxis as requiring three or more appropriate doses or initiation of IV epinephrine infusion with adjunctive management. PubMedManagement of Refractory Anaphylaxis: An Overview of Current Guidelines

References

  1. DailyMed - ADRENALIN- epinephrine injectiondailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  2. - IIER - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  3. These highlights do not include all the information needed to use EPINEPHRINE INJECTION safely and effectively. See full prescribing information for EPINEPHRINE INJECTION. EPINEPHRINE injection, for intravenous, intramuscular, subcutaneous useInitial U.S. Approval: 1939dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  4. safely and effectively. See full prescribing information ...dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  5. highlights of prescribing informationdailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  6. Food and Drug Administrationwww.accessdata.fda.gov · www.accessdata.fda.gov
  7. Multiphasic anaphylaxis in the emergency and intensive care setting | BMJ Case Reportscasereports.bmj.com · casereports.bmj.com
  8. Guidelines for the management of anaphylaxis in ...emj.bmj.com · emj.bmj.com
  9. G462(P) Anaphylaxis nice guidelines: are we following ...adc.bmj.com · adc.bmj.com
  10. Anaphylaxis - Symptoms, diagnosis and treatment | BMJ Best Practicebestpractice.bmj.com · bestpractice.bmj.com
  11. Anaphylaxis: a guide to management Online coursenew-learning.bmj.com · new-learning.bmj.com
  12. Anaphylaxis - Symptoms, diagnosis and treatment | BMJ Best Practice USbestpractice.bmj.com · bestpractice.bmj.com
  13. Integrated phase I pharmacokinetics and ...www.sciencedirect.com · www.sciencedirect.com
  14. Review Innovations in the treatment of anaphylaxiswww.sciencedirect.com · www.sciencedirect.com
  15. Generic substitution of epinephrine autoinjectorswww.sciencedirect.com · www.sciencedirect.com
  16. Pediatric drug-induced anaphylaxis reports in the FDA ...www.sciencedirect.com · www.sciencedirect.com
  17. NATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...www.nice.org.uk · www.nice.org.uk
  18. A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  19. Overview | Anaphylaxis: assessment and referral after emergency treatment | Guidance | NICEwww.nice.org.uk · www.nice.org.uk
  20. Management of Refractory Anaphylaxis: An Overview of Current Guidelinespmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  21. Evaluating the management of anaphylaxis in US emergency departments: Guidelines vs. practicepmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  22. Recent update on the management of anaphylaxispmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  23. Anaphylaxis - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  24. Anaphylaxis - StatPearls - NCBI Bookshelf - NIHwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov